(Q33357503)

26 July 2017

1 reference

title

The use of folic acid for the prevention of neural tube defects and other congenital anomalies (English)

1 reference

26 July 2017

The Use of Folic Acid for the Prevention of Neural Tube Defects and Other Congenital Anomalies (English)

1 reference

https://api.crossref.org/works/10.1016/S1701-2163(16)30248-1

30 March 2024

0 references

1 reference

1 reference

5

Anne Summers

1 reference

26 July 2017

Gregory Davies

2

1 reference

26 July 2017

Valérie Désilets

3

1 reference

26 July 2017

Philip Wyatt

6

1 reference

26 July 2017

David Young

7

1 reference

26 July 2017

Genetics Committee and Executive and Council of the Society of Obstetricians and Gynaecologists of Canada

8

1 reference

26 July 2017

R. Douglas Wilson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608448

30 March 2024

Gregory J. Reid

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608448

30 March 2024

Anne Summers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608448

30 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14608448

30 March 2024

publication date

1 November 2003

1 reference

full work available at URL

26 July 2017

https://api.elsevier.com/content/article/PII:S1701216316302481?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1701-2163(16)30248-1

https://api.elsevier.com/content/article/PII:S1701216316302481?httpAccept=text/plain

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1701-2163(16)30248-1

Journal of Obstetrics and Gynaecology Canada

30 March 2024

published in

1 reference

26 July 2017

25

1 reference

26 July 2017

11

1 reference

26 July 2017

959-973

1 reference

Prevention of congenital abnormalities by periconceptional multivitamin supplementation

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Case-Control Study of Periconceptional Folic Acid Supplementation and Oral Clefts

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Neural tube defects in Eastern Ontario and Western Quebec: demography and family data

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Epidemiological studies of neural tube defects in Newfoundland

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Date of conception and prevention of neural tube defects.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Sib risks of anencephaly and spina bifida in British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Prenatal diagnosis of fetal anomalies during the second trimester of pregnancy: Their characterization and delineation of defects in pregnancies at risk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Neural tube defects in British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Neural tube defects in the Sikhs

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Etiologic Heterogeneity of Neural-Tube Defects

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Etiologic heterogeneity of neural tube defects: clues from epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Prevalence of aneuploidy and additional anatomic abnormalities in fetuses with open spina bifida: population based study in Utah

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Teratogen update: valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Spina bifida in infants of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Aminopterin and methotrexate: folic acid deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Sonography of fetal cerebrospinal anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Periconceptional use of multivitamins and the occurrence of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Quantifying the effect of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Effects of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Effects of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Effects of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

The prevention of congenital anomalies with periconceptional folic acid supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Teratology Society position paper: recommendations for vitamin A use during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930248-1

7 January 2021

Identifiers

0 references

1 reference